InvestorsHub Logo
Followers 2090
Posts 61313
Boards Moderated 4
Alias Born 11/08/2009

Re: Billionairestatus12 post# 33594

Wednesday, 03/26/2014 11:17:50 AM

Wednesday, March 26, 2014 11:17:50 AM

Post# of 50668
MCET: "Current approaches for treatment of hepatocellular carcinoma are of limited efficacy. MCT-485, possessing both oncolytic and immune activating properties, could be superior to doxorubicin, cisplatin and other currently marketed therapies by providing a more robust activation of immunity, and a more global and longer lasting anti-tumor effect."

Learn how to analyze Charts & interpret Japanese candlestick patterns........link below...........$$$

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=86130044